ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05164	Influenza A	17/144	167/7206	2.88253212125e-08
ko04380	Osteoclast differentiation	15/144	134/7206	5.56790951486e-08
ko05145	Toxoplasmosis	14/144	126/7206	1.74138713664e-07
ko04621	NOD-like receptor signaling pathway	15/144	157/7206	4.57580176644e-07
ko05340	Primary immunodeficiency	7/144	30/7206	1.52378188745e-06
ko05140	Leishmaniasis	10/144	75/7206	2.0301839467e-06
ko04064	NF-kappa B signaling pathway	11/144	96/7206	2.85233634734e-06
ko05152	Tuberculosis	15/144	187/7206	4.22914645568e-06
ko05162	Measles	12/144	120/7206	4.25063608945e-06
ko04060	Cytokine-cytokine receptor interaction	15/144	191/7206	5.49280998452e-06
ko04660	T cell receptor signaling pathway	12/144	124/7206	5.99592902411e-06
ko04650	Natural killer cell mediated cytotoxicity	10/144	97/7206	2.11767726896e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	14/144	191/7206	2.5157471939e-05
ko04217	Necroptosis	13/144	178/7206	5.15475854304e-05
ko05133	Pertussis	9/144	87/7206	5.39608667684e-05
ko04612	Antigen processing and presentation	8/144	77/7206	0.000137546718405
ko05168	Herpes simplex infection	12/144	182/7206	0.000265958961315
ko04145	Phagosome	11/144	162/7206	0.000374601669724
ko04658	Th1 and Th2 cell differentiation	8/144	96/7206	0.000630156425808
ko04062	Chemokine signaling pathway	12/144	201/7206	0.000656026952571
ko04666	Fc gamma R-mediated phagocytosis	9/144	122/7206	0.000710142777097
ko04672	Intestinal immune network for IgA production	5/144	37/7206	0.000774057469936
ko04670	Leukocyte transendothelial migration	10/144	151/7206	0.000842689327828
ko04659	Th17 cell differentiation	8/144	106/7206	0.00121226723467
ko04630	Jak-STAT signaling pathway	9/144	132/7206	0.0012480211505
ko05160	Hepatitis C	9/144	153/7206	0.00344177491577
ko04620	Toll-like receptor signaling pathway	7/144	100/7206	0.00374361475316
ko04664	Fc epsilon RI signaling pathway	6/144	77/7206	0.00424496408408
ko05321	Inflammatory bowel disease (IBD)	5/144	56/7206	0.00500906836824
ko05150	Staphylococcus aureus infection	4/144	36/7206	0.00548351990753
ko05161	Hepatitis B	9/144	173/7206	0.00764777058161
ko05166	HTLV-I infection	13/144	292/7206	0.00789918127107
ko04662	B cell receptor signaling pathway	6/144	88/7206	0.00811809108757
ko04623	Cytosolic DNA-sensing pathway	4/144	41/7206	0.00873047618167
ko04215	Apoptosis - multiple species	4/144	47/7206	0.0140278672544
ko05146	Amoebiasis	6/144	99/7206	0.0140537301871
ko05142	Chagas disease (American trypanosomiasis)	7/144	130/7206	0.0150940092256
ko04611	Platelet activation	8/144	163/7206	0.016166227168
ko01524	Platinum drug resistance	5/144	76/7206	0.0176573052741
ko04080	Neuroactive ligand-receptor interaction	2/144	423/7206	0.0178235392822
ko04610	Complement and coagulation cascades	5/144	79/7206	0.0205475741541
ko04142	Lysosome	7/144	151/7206	0.0312922245868
ko05323	Rheumatoid arthritis	5/144	89/7206	0.0323530747195
ko04668	TNF signaling pathway	6/144	120/7206	0.0327052828829
ko04622	RIG-I-like receptor signaling pathway	4/144	62/7206	0.0349322477524
ko05310	Asthma	2/144	17/7206	0.0443300303043
ko05132	Salmonella infection	5/144	98/7206	0.046002276247